Should schizophrenia be treated as a neurocognitive disorder?

Area of Science:

• Psychiatry
• Neuroscience
• Cognitive Science

Background:

• Schizophrenia is characterized by significant neurocognitive deficits.
• Existing psychopharmacological and cognitive/behavioral interventions show emerging but fragmented results.
• A lack of integrating frameworks hinders the systematic advancement of treatment research.

Purpose of the Study:

• To present three models of increasing complexity to understand neurocognitive deficits in schizophrenia.
• To elucidate the relationship between neurocognitive deficits, treatment, and outcomes.
• To address methodological and interpretive challenges in neurocognitive intervention research.

Main Methods:

• Conceptual modeling approach.
• Discussion of methodological issues including direct/indirect medication effects, construct selection, and validity.
• Exploration of interpretive challenges such as treatment durability and efficacy definition.

Main Results:

• The proposed models offer a framework for investigating neurocognitive deficits in schizophrenia.
• Identified key challenges include defining successful interventions and relevant outcomes.
• Highlighted the need to reconsider treatment efficacy metrics.

Conclusions:

• Clear guidelines are crucial for testing and interpreting neurocognitive interventions in schizophrenia.
• The field is moving towards modifying neurocognitive deficits, necessitating refined outcome measures.
• Further research is needed to establish effective and durable interventions for schizophrenia.